A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function ; volume:7 ; number:1 ; day:9 ; month:9 ; year:2019 ; pages:1-13 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (9.9.2019), 1-13, 12.2019
- Urheber
-
Hoogi, Shiran
Eisenberg, Vasyl
Mayer, Shimrit
Shamul, Astar
Barliya, Tilda
Cohen, Cyrille J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0721-y
- URN
-
urn:nbn:de:101:1-2020012422533592543592
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoogi, Shiran
- Eisenberg, Vasyl
- Mayer, Shimrit
- Shamul, Astar
- Barliya, Tilda
- Cohen, Cyrille J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Modulating T-cell activation with tunable stimulatory nanoarrays
Chimeric Antigen Receptor T-Cell Therapy
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Modulating T-cell activation with tunable stimulatory nanoarrays
Chimeric Antigen Receptor T-Cell Therapy
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Modulating T-cell activation with tunable stimulatory nanoarrays
Chimeric Antigen Receptor T-Cell Therapy
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice